Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1100 participants
OBSERVATIONAL
2021-11-29
2027-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biologic Characterization of Patients With ITP
NCT05694325
Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)
NCT06665308
National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients
NCT07268898
The International ITP Registry
NCT01970189
The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.
NCT01101295
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In recent years, new treatment options for patients with immune thrombocytopenia have emerged.
The results of published clinical studies on ITP can only be used for broad patient care to a limited extent, as they are designed for a patient population with clearly defined inclusion and exclusion criteria. Real world data collected from this registry will help to better understand the diagnosis and therapy of ITP patients in everyday treatment and to more effectively direct individual patients to optimal therapy, thus improving their outcomes.
By collecting biospecimens, this project will contribute new knowledge to the study of ITP through standardized, systematic, and high-quality collection and storage of patient samples and associated data.
The registry collects clinical data from patients diagnosed with ITP at defined points in the course of the disease. The Data collection includes a range of clinical measures, disease-related factors, treatment/treatment course and outcomes, complications during treatment and Qol, fatigue scoring and survival data (up to 5 years).
The data are collected prospectively. In addition, patients can be included retrospectively up to 12 months after the initial diagnosis if continuous documentation can be provided at the treatment centre. In both cases, a written declaration of consent is obligatory.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥18 years
* signed declaration of consent
Exclusion Criteria
* no informed consent possible (this covers patients who are unable to understand the nature and scope of participation)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Dresden
OTHER
Novartis
INDUSTRY
Swedish Orphan Biovitrum
INDUSTRY
Grifols Biologicals, LLC
INDUSTRY
Amgen
INDUSTRY
argenx
INDUSTRY
Jena University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas Stauch
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Stauch, Dr. med.
Role: STUDY_DIRECTOR
Jena University Hospital
Karolin Trautmann-Grill, Dr. med.
Role: STUDY_DIRECTOR
Dresden Univeristy Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitätsklinikum Aachen AöR
Aachen, , Germany
Klinikum Altenburger Land GmbH, Klinik für Innere Medizin/Hämatologie/Onkologie
Altenburg, , Germany
MVZ am Klinikum Aschaffenburg
Aschaffenburg, , Germany
MVZ IMD GmbH, IMD Gerinnungszentrum Hochtaunus
Bad Homburg, , Germany
Onkologie/Hämatologie
Bad Liebenwerda, , Germany
Charité Universitätsmedizin Berlin
Berlin, , Germany
Praxis für Hämatologie und Onkologie Berlin-Mitte
Berlin, , Germany
Vivantes Netzwerk für Gesundheit GmbH, Klinikum am Friedrichshain
Berlin, , Germany
Onkologie am Segelfliegerdamm
Berlin, , Germany
MVZ Hämatologikum GmbH
Biberach, , Germany
Augusta-Kranken-Anstalt gGmbH
Bochum, , Germany
Klinikum Chemnitz gGmbH
Chemnitz, , Germany
MVZ Klinikum Coburg GmbH
Coburg, , Germany
Klinikum Darmstadt
Darmstadt, , Germany
ARGE e.V.
Donauwörth, , Germany
Onkozentrum Dresden/Freiberg
Dresden, , Germany
Gemeinschaftspraxis Hämatologie-Onkologie
Dresden, , Germany
Gemeinschaftspraxis Mohm & Prange-Krex
Dresden, , Germany
Universitätsklinikum Dresden
Dresden, , Germany
Krankenhaus Düren gGmbH
Düren, , Germany
Onkologische Praxis Erfurt
Erfurt, , Germany
Universitätsklinikum Erlangen
Erlangen, , Germany
MVZ für Hämatologie und Onkologie Essen
Essen, , Germany
Universitätsklinikum Frankfurt
Frankfurt am Main, , Germany
Haemostas-Frankfurt
Frankfurt am Main, , Germany
PIOH Studien und Management GbR
Frechen, , Germany
Fachärztliche Gemeinschaftspraxis Panagiotou/Minaei
Garbsen, , Germany
IOGP Gera MVZ GmbH
Gera, , Germany
ALB FILS Kliniken, Klinik am Eichert
Göppingen, , Germany
Universitätsklinik Greifswald
Greifswald, , Germany
Katholisches Krankenhaus Hagen gGmbH
Hagen, , Germany
Gemeinschaftspraxis, FA für Innere Medizin
Halle, , Germany
MVZ III Onkologie der evidia MVZ Halle (Saale) GmbH
Halle, , Germany
Onko-Kolleg GmbH & Co. KG, HOPA MVZ GmbH
Hamburg, , Germany
Werlhof-Institut MVZ GmbH
Hanover, , Germany
Onkologie am Raschplatz
Hanover, , Germany
Dres. Kamal & Dorn GbR
Hanover, , Germany
ODZ-Petersen GmbH
Heidenheim, , Germany
St. Bernward Krankenhaus GmbH
Hildesheim, , Germany
Klinikum Idar-Oberstein GmbH
Idar-Oberstein, , Germany
University Hospital Jena
Jena, , Germany
Klinikum Kassel GmbH
Kassel, , Germany
Universitätsklinikum Schleswig-Holstein
Kiel, , Germany
Gemeinschaftsklinikum Mittelrhein gGmbH, Ev. Stift St. Martin
Koblenz, , Germany
Ambulantes Zentrum für Hämatologie, Onkologie und Gerinnung
Kronach, , Germany
MVZ mbH, Onkologische Schwerpunktpraxis
Leer, , Germany
Universitätsklinikum Leipzig
Leipzig, , Germany
OnkoFor Leipzig GmbH
Leipzig, , Germany
Universitätsklinikum Magdeburg, Klinik für Hämatologie, Onkologie und Zelltherapie
Magdeburg, , Germany
Carl-von-Basedow Klinikum Merseburg
Merseburg, , Germany
Gemeinschaftspraxis Hämato-Onkologie
München, , Germany
Dietrich-Bonhoeffer-Klinikum Neubrandenburg
Neubrandenburg, , Germany
MVZ Onko Medical GmbH Neustadt
Neustadt am Rübenberge, , Germany
Pi.Tri.-Studien GmbH
Offenburg, , Germany
Elblandkliniken Stiftung & Co. KG, Elblandklinikum Riesa
Riesa, , Germany
Klinikum Südstadt Rostock
Rostock, , Germany
Medcenter Nordsachsen
Schkeuditz, , Germany
MVZ am Schlossgarten, Zero Praxen
Schwetzingen, , Germany
Onkologiezentrum Soest/Iserlohn
Soest, , Germany
Bundeswehrkrankenhaus Ulm
Ulm, , Germany
Schwarzwald-Baar. Klinikum Villingen-Schwenningen GmbH
Villingen-Schwenningen, , Germany
Onkologisches Zentrum Wolfsburg-Helmstadt MVZ GmbH
Wolfsburg, , Germany
Universitätsklinikum Würzburg
Würzburg, , Germany
Praxis für Hämatologie und Internistische Onkologie
Zittau, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Gerda Silling, Dr
Role: primary
Christina Klötzer, Dr.
Role: primary
Manfred Welslau, Dr.
Role: primary
Rosa Sonja Alesci, Dr
Role: primary
Stephan Kreher, PD Dr.
Role: primary
Marie Luise Hütter-Krönke, Dr.
Role: primary
Stephan Fuhrmann, Dr.
Role: primary
Robert Klamroth, PD Dr.
Role: primary
Jörg Heßling, Dr.
Role: primary
Leonid Basovski, Dr.
Role: primary
Robert Radkowski, Dr.
Role: primary
Mathias Hänel, PD Dr.
Role: primary
Christof Lamberti, PD Dr.
Role: primary
Bastian Fleischmann
Role: primary
Steffen Dörfel
Role: primary
Thomas Illmer, PD Dr.
Role: primary
Johannes Mohm, Dr.
Role: primary
Karolin Trautmann-Grill, Dr.
Role: primary
Michael Flaßhove, PD Dr.
Role: primary
Ulrich Hauch, Dr.
Role: primary
Valeska Brückl, Dr.
Role: primary
Patricia Johansson, PD Dr.
Role: primary
Jörg Chromik, Dr.
Role: primary
Wolfgang Mondorf, Dr.
Role: primary
Marcel Reiser, PD Dr.
Role: primary
Petros Panagiotou
Role: primary
Steffen Gerhardt, Dr.
Role: primary
Johannes Niebling, Dr.
Role: primary
Thomas Neumann, Dr.
Role: primary
Doris Kraemer, Prof. Dr.
Role: primary
Regina Moeller, Dr.
Role: primary
Timo Behlendorf, Dr.
Role: primary
Julia Wiederhold
Role: primary
Kai Gutensohn, Prof. Dr.
Role: primary
Eyck von der Heyde, Dr.
Role: primary
Haytham Kamal, Dr.
Role: primary
Volker Petersen, Dr.
Role: primary
Ulrich Kaiser, Prof. Dr.
Role: primary
Marina Bischoff, Dr.
Role: primary
Thomas Stauch, MD
Role: primary
Martin Wolf, Prof. Dr.
Role: primary
Matthias Ritgen, Dr.
Role: primary
Jens-Marcus Chemnitz, Dr.
Role: primary
Martina Stauch, Dr.
Role: primary
Lothar Müller, Dr.
Role: primary
Carmen Herling, Dr.
Role: primary
Andreas Schwarzer, Dr.
Role: primary
Tobias Ronny Haage, Dr.
Role: primary
Susann Schulze, Dr.
Role: primary
Matthias Zingerle, Dr.
Role: primary
Philipp Hemmati, PD Dr.
Role: primary
Munir Rababah, Dr.
Role: primary
Henning Pelz, Dr.
Role: primary
Jörg Schubert, Prof. Dr.
Role: primary
Beate Krammer-Steiner, Dr.
Role: primary
Leanthe Braunert, Dr.
Role: primary
Christian Kuhn, Dr.
Role: primary
Anke Wortmann, Dr.
Role: primary
Matthias Müller, Dr.
Role: primary
Paul La Rosée, Prof. Dr.
Role: primary
Thomas Gabrysiak, Dr.
Role: primary
Thomas Bumm, Dr.
Role: primary
Mathias Schulze, Dr.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZKSJ0142
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.